Ascentage Pharma Group International (AAPG) Other Non-Current Assets: 2022-2024
Historic Other Non-Current Assets for Ascentage Pharma Group International (AAPG) over the last 3 years, with Dec 2024 value amounting to $8.1 million.
- Ascentage Pharma Group International's Other Non-Current Assets rose 138.42% to $8.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $8.1 million, marking a year-over-year increase of 138.42%. This contributed to the annual value of $8.1 million for FY2024, which is 134.01% up from last year.
- As of FY2024, Ascentage Pharma Group International's Other Non-Current Assets stood at $8.1 million, which was up 134.01% from $3.5 million recorded in FY2023.
- In the past 5 years, Ascentage Pharma Group International's Other Non-Current Assets ranged from a high of $8.1 million in FY2024 and a low of $2.5 million during FY2022.
- Its 3-year average for Other Non-Current Assets is $4.7 million, with a median of $3.5 million in 2023.
- Data for Ascentage Pharma Group International's Other Non-Current Assets shows a peak YoY soared of 134.01% (in 2024) over the last 5 years.
- Over the past 3 years, Ascentage Pharma Group International's Other Non-Current Assets (Yearly) stood at $2.5 million in 2022, then skyrocketed by 40.43% to $3.5 million in 2023, then skyrocketed by 134.01% to $8.1 million in 2024.